NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nanjing Polymer Medical Technology Co., Ltd.

Nanjing Polymer Medical Technology Co., Ltd.

Private
NanjingHealthcare & Life Scienceshttps://www.njpolymer.cn/

Last Round

Series C

Jul 31, 2025

Total Funding Raised

$94.8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nanjing Polymer Medical Technology Co., Ltd. is a medical devices company that develops and produces absorbable medical devices based on biodegradable polymer materials for use in general surgery, neurosurgery, and medical cosmetology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Fashion & Beauty

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

surgical suturesbiodegradable polymersmedical devicesabsorbable implantscranial fixationpolydioxanonePPDOfacial fillersbiomaterialsmedical aestheticsbioresorbable materialsneurosurgical devicesbio-implantssurgical consumablespolylactic acidPLA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanjing Polymer Medical Technology Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Nanjing Polymer Medical Technology Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nanjing Polymer Medical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 31, 2025
Series B ExtensionJul 24, 2025
Series BApr 24, 2023
StrategicMar 1, 2022

Nanjing Polymer Medical Technology Co., Ltd. Investors

Notable investors and investment history

Nanjing Polymer Medical Technology Co., Ltd. investors
InvestorRounds
Alwin CapitalSeries C
Huatai Zijin Investment Co., Ltd.Series B, Series B Extension
Mirae Asset Securities (HK) Ltd.Series C
Huatai Zijin InvestmentSeries B, Series B Extension
Huatai Zijin InvestmentSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 31, 2025

    Raised $50M from Huatai Zijin Investment and Alwin Capital.

Nanjing Polymer Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nanjing Polymer Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanjing Polymer Medical Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNanjing
Year Founded2016
Last FundingJul 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.